SEK 1.28
(-1.54%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - SEK | 0.0% |
2022 | - SEK | 0.0% |
2021 | - SEK | 0.0% |
2020 | - SEK | 0.0% |
2019 | - SEK | -100.0% |
2018 | 1.24 Million SEK | 14.77% |
2017 | 1.08 Million SEK | -48.01% |
2016 | 2.08 Million SEK | -33.34% |
2015 | 3.12 Million SEK | 0.0% |
2014 | - SEK | 0.0% |
2013 | - SEK | -100.0% |
2012 | 1.25 Million SEK | 0.0% |
2011 | - SEK | 0.0% |
2010 | - SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - SEK | 0.0% |
2023 Q3 | - SEK | 0.0% |
2023 FY | - SEK | 0.0% |
2023 Q1 | - SEK | 0.0% |
2023 Q4 | - SEK | 0.0% |
2023 Q2 | - SEK | 0.0% |
2022 Q1 | - SEK | 0.0% |
2022 Q2 | - SEK | 0.0% |
2022 FY | - SEK | 0.0% |
2022 Q3 | - SEK | 0.0% |
2022 Q4 | - SEK | 0.0% |
2021 Q3 | - SEK | 0.0% |
2021 Q4 | - SEK | 0.0% |
2021 FY | - SEK | 0.0% |
2021 Q1 | - SEK | 0.0% |
2021 Q2 | - SEK | 0.0% |
2020 Q2 | - SEK | 0.0% |
2020 FY | - SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2020 Q4 | - SEK | 0.0% |
2020 Q3 | - SEK | 0.0% |
2019 Q3 | - SEK | -100.0% |
2019 FY | - SEK | -100.0% |
2019 Q4 | - SEK | 0.0% |
2019 Q2 | 83 Thousand SEK | -89.94% |
2019 Q1 | 825 Thousand SEK | -33.63% |
2018 Q1 | 833 Thousand SEK | -23.08% |
2018 FY | 1.24 Million SEK | 14.77% |
2018 Q4 | 1.24 Million SEK | -32.0% |
2018 Q3 | 1.82 Million SEK | -4.44% |
2018 Q2 | 1.91 Million SEK | 129.65% |
2017 Q1 | 1.83 Million SEK | -12.0% |
2017 Q4 | 1.08 Million SEK | -18.75% |
2017 Q3 | 1.33 Million SEK | -15.79% |
2017 Q2 | 1.58 Million SEK | -13.64% |
2017 FY | 1.08 Million SEK | -48.01% |
2016 Q4 | 2.08 Million SEK | -32.44% |
2016 Q2 | 3.33 Million SEK | 6.66% |
2016 Q3 | 3.08 Million SEK | -7.5% |
2016 Q1 | 3.12 Million SEK | 0.0% |
2016 FY | 2.08 Million SEK | -33.34% |
2015 Q2 | 4 Million SEK | 60.0% |
2015 Q4 | 3.12 Million SEK | -21.88% |
2015 Q3 | 4 Million SEK | 0.0% |
2015 FY | 3.12 Million SEK | 0.0% |
2015 Q1 | 2.5 Million SEK | 0.0% |
2014 FY | - SEK | 0.0% |
2014 Q3 | - SEK | 0.0% |
2014 Q2 | - SEK | 0.0% |
2014 Q1 | - SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2013 Q4 | - SEK | -100.0% |
2013 FY | - SEK | -100.0% |
2013 Q1 | - SEK | -100.0% |
2013 Q3 | 875 Thousand SEK | 0.0% |
2012 Q4 | 1.25 Million SEK | 0.0% |
2012 FY | 1.25 Million SEK | 0.0% |
2011 FY | - SEK | 0.0% |
2010 FY | - SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acarix AB (publ) | - SEK | NaN% |
ADDvise Group AB (publ) | 1.45 Billion SEK | 100.0% |
ADDvise Group AB (publ) | 1.45 Billion SEK | 100.0% |
Arcoma AB | 1.92 Million SEK | 100.0% |
Bactiguard Holding AB (publ) | 42.3 Million SEK | 100.0% |
BICO Group AB (publ) | 1.75 Billion SEK | 100.0% |
Boule Diagnostics AB (publ) | 57.7 Million SEK | 100.0% |
CellaVision AB (publ) | 28.66 Million SEK | 100.0% |
Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | 100.0% |
Chordate Medical Holding AB (publ) | - SEK | NaN% |
C-Rad AB (publ) | 1.75 Million SEK | 100.0% |
Duearity AB (publ) | 2.94 Million SEK | 100.0% |
Dignitana AB (publ) | 6.07 Million SEK | 100.0% |
Episurf Medical AB (publ) | 2.3 Million SEK | 100.0% |
Getinge AB (publ) | 3.9 Billion SEK | 100.0% |
Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | 100.0% |
Iconovo AB (publ) | 4.9 Million SEK | 100.0% |
Integrum AB (publ) | 4.84 Million SEK | 100.0% |
Luxbright AB (publ) | 206.02 Thousand SEK | 100.0% |
Mentice AB (publ) | 2.14 Million SEK | 100.0% |
OssDsign AB (publ) | 214 Thousand SEK | 100.0% |
Paxman AB (publ) | 2.53 Million SEK | 100.0% |
Promimic AB (publ) | - SEK | NaN% |
Qlife Holding AB (publ) | 3 Million SEK | 100.0% |
SciBase Holding AB (publ) | 4.17 Million SEK | 100.0% |
Sectra AB (publ) | 19.2 Million SEK | 100.0% |
Sedana Medical AB (publ) | 1.01 Million SEK | 100.0% |
Senzime AB (publ) | 8.57 Million SEK | 100.0% |
SpectraCure AB (publ) | 4.39 Million SEK | 100.0% |
Stille AB | 38.06 Million SEK | 100.0% |
Vitrolife AB (publ) | 1.87 Billion SEK | 100.0% |
Xvivo Perfusion AB (publ) | 21.16 Million SEK | 100.0% |